IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

Go back to IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine
Waters Corporation (NYSE: WAT) Delayed: 380.37 +9.55 (2.58%)
Previous Close $370.82    52 Week High $162.53 
Open $378.94    52 Week Low $112.00 
Day High $389.99    P/E 73.15 
Day Low $375.05    EPS $5.20 
Volume 704,721